XENOME LIMITED Pages on BioPortfolio:

BioPortfolio - xenome
Xenome Limited - Entry on Bioportfolio's Biocorporate Database. ... View the current Xenome Limited Page on BioPortfolio.com . ...
http://www.bioportfolio.com/search/xenome.html...

BioPortfolio - xenome ltd
xenome ltd - BioPortfolio. ... Xenome Limited - Entry on Bioportfolio's Biocorporate Database. http://www.bioportfolio.com/biocorporate/11089-
Xenome_Limite. ...
http://www.bioportfolio.com/search/xenome_ltd.html...

BioPortfolio - Xenome Ltd Queensland
Xenome Ltd Queensland - BioPortfolio. ... Xenome Ltd Strengthens Management Team And Launches US Presence ... Previously Kathryn was founding Chief . ...
http://www.bioportfolio.com/search/Xenome_Ltd_Queensland.htm...

BioPortfolio - xenome ltd pipeline
xenome ltd pipeline - BioPortfolio. ... Xenome Ltd. was established to mine the diverse therapeutic potential of Australia's terrestrial and marine biota, ...
http://www.bioportfolio.com/search/xenome_ltd_pipeline.html...

BioPortfolio - XENOME LIMITED
XENOME LIMITED - BioPortfolio. ... Xenome Limited - Entry on Bioportfolio's Biocorporate Database. ...
http://www.bioportfolio.com/search/XENOME_LIMITED.html...

BioPortfolio - Xenome in indooroopilly
Xenome Ltd 120 Meiers Road Indooroopilly Queensland 4068 Australia . ... Xenome Ltd Presents Xen2174 Data on Relief of Pain in Cancer Patients 8/21/2008 . ...
http://www.bioportfolio.com/search/Xenome_in_indooroopilly.h...

BioPortfolio - Xenome qld
Xenome Ltd Strengthens Management Team And Launches US Presence . ... Xenome Ltd . ABN 60 081 612 384 120 Meirs Rd. Indooroopilly, Brisbane, QLD 4068, ...
http://www.bioportfolio.com/search/Xenome_qld.html...

Results from other life science and pharmaceutical sites:

Xenome Ltd Launches MultiCentre Clinical Trial For Severe Cancer ...
15 /PRNewswire/ -- Xenome Limited today announced it had commenced a Phase I/IIa trial of Xen2174, a new class of peptide therapeutic for the treatment of ...
http://www.biospace.com/news_story.aspx?NewsEntityId=2694...

7 May 2003 Company Announcements Office Australian Stock Exchange ...
XENOME ANNOUNCES SUCCESSFUL $250000 FEDERAL GOVERNMENT BIF GRANT. Xenome Limited is pleased to announce that the company has been awarded a round four ...
http://www.cytopia.com.au/pdf/2003/05-07-03%20-%20Announceme...

Xenome Ltd Presents Xen2174 Data on Relief of Pain in Cancer ...
A new drug for the treatment of severe pain under development by Australian biotechnology company Xenome Limited (“Xenome”) has shown promise for the relief
...
http://www.biospace.com/news_story.aspx?NewsEntityId=107530...

Media Release XENOME’S PAIN DRUG XEN2174 ENTERS HUMAN CLINICAL ...
Xenome Limited last month gained Investigatory New Drug approval by the US Federal ... Xenome Limited, announced today that a Phase I clinical trial had
...
http://www.cytopia.com.au/pdf/2004/07-20-04%20-%20Announceme...

Xenome Names Ian T. Nisbet, PhD as Chief Executive Officer
5 /PRNewswire/ -- Xenome Limited today announced the appointment of Ian Nisbet ... Further information: Ian Nisbet, Chief Executive Officer Xenome Ltd. Tel:
...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...

22 May 2003 Company Announcements Office Australian Stock Exchange ...
Medica investee Xenome granted European Patent. 22 May 2003. Page 2. Thursday 22 May 2003. Media Release. Source: XENOME LIMITED. XENOME PATENT GRANTED IN ...
http://www.cytopia.com.au/pdf/2003/05-22-03%20-%20Announceme...

Leading Bioscience Fund GBS Invests $6 Million in Xenome L ...
Brisbane, Australia, 23 July 2008: Biopharmaceutical company Xenome Limited (“ Xenome”) today announced it has received a convertible note placement of US$6
...
http://www.biospace.com/news_story.aspx?NewsEntityId=104199...

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright 1997-2008 - BioPortfolio Limited.